WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced a strategic partnership with the Qatar Free Zones Authority (QFZ) to expand its global footprint into the Middle East.

 

The Memorandum of Understanding (MoU) was signed by Dr Chris Chen, CEO of WuXi Biologics, and Sheikh Mohammed Bin Hamad Bin Faisal Al-Thani, CEO of QFZ, in a ceremony witnessed by Sheikh Faisal bin Thani bin Faisal Al-Thani, Minister of Commerce and Industry – State of Qatar and Chairman of QFZ.

 

This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region. 

 

By combining WuXi Biologics’ one-stop CRDMO solutions and expertise in complex biologics—such as bispecifics, multispecifics, and antibody-drug conjugates—with Qatar’s strategic vision for biopharmaceutical innovation, the partnership aims to accelerate growth in Qatar’s biotech sector and build a robust Middle Eastern biopharmaceutical ecosystem, the CDMO player has said.

 

Dr Chris Chen, CEO of WuXi Biologics, said: “This partnership is a pivotal step for WuXi Biologics. It marks the beginning of our journey in the region while extending our global network and capabilities. 

 

"Qatar’s forward-looking vision for the biopharmaceutical sector, underpinned by QFZ’s integrated ecosystem and reliable connectivity, provides a compelling platform for innovation and advanced manufacturing. We look forward to contributing to this growing ecosystem while enabling our clients to deliver high-quality, life-saving treatments to patients around the world.”

 

Sheikh Mohammed Bin Hamad Bin Faisal Al-Thani, CEO of QFZ, added: “This partnership strengthens Qatar’s position as one of the region’s most reliable locations for biopharmaceutical growth. By combining WuXi Biologics’ global expertise with Qatar’s advanced healthcare ecosystem, supportive regulatory landscape, and exceptional logistics connectivity, we are creating an environment for sustained biopharmaceutical innovation and high-value manufacturing. 

 

"We are committed to fostering strategic partnerships that expand global capacity, accelerate breakthroughs, and position Qatar as a hub for the industries of the future.”